Zhejiang Medicine (600216.SS) – Market Overview
- Current trading activity: The stock closed unchanged at 0 % during the 24‑hour period ending 02:12 PM Central Europe on Friday, 23 March.
- Price: One share is trading at CNH 11.91 on major exchanges.
- Supply and volume: 961.6 million shares are currently available. In the last 24 hours, CNH 114.8 million worth of shares were traded.
- Market capitalization: CNH 1.6 billion.
- Recent performance: Since the end of the previous month, the share price has fallen 6.11 %.
- Technical indicators:
- 200‑day simple moving average: CNH 12.38.
- 52‑week high: CNH 18.58 (09 March 2026).
- 52‑week low: CNH 10.94 (29 June 2026).
Regulatory Developments Impacting Zhejiang Medicine
China’s securities regulator has announced plans to tighten oversight of listed‑company spin‑offs. The goal is to reduce the practice of separating profitable units for new listings, citing fairness to shareholders and potential business overlap concerns.
- Effect on pending spin‑offs: Several firms, including those with microelectronics and robotics units, have postponed or abandoned spin‑off plans.
- Current approvals: Applications involving a biotech subsidiary of Zhejiang Medicine and an overseas mining subsidiary remain under review. Detailed rules are expected next year; no formal guidelines have yet been released.
- Market context: The policy shift follows heightened investor caution and volatility, especially in technology sectors where China has significant influence.
Related Stock Performance (Last 24 Hours)
| Stock | Symbol | Change | Current Price | Market Cap | P/E Ratio |
|---|---|---|---|---|---|
| Zhongtian Service | 002188.SZ | 0 % | CNY 5.22 | CNY 1.8 bn | 64.52 |
| China Automotive Engineering | 601965.SS | 0 % | CNH 13.76 | CNH 1.9 bn | 12.79 |
| Tiansheng | 300169.SZ | 0 % | CNY 5.09 | CNY 1.8 bn | 27.21 |
| Meter Instruments | 301006.SZ | 0 % | CNY 12.94 | CNY 1.8 bn | 28.84 |
| Meitu | 1357.HK | –4.72 % | HKD 3.66 | HKD 2.1 bn | 14.93 |
Meitu update: The company reported that its new Kling 4.0 API is now available across multiple platforms, offering advanced visual realism and creative features. Shares fell modestly in response.
Company Profile – Zhejiang Medicine
Zhejiang Medicine Co., Ltd. operates in the pharmaceutical sector, headquartered in Shaoxing, China. The company manufactures and markets chemical medicines, including antibiotics and vitamins, and engages in food manufacturing through its subsidiaries. The IPO was launched on 11 August 1999 and the company is listed on the Shanghai Stock Exchange. Further information is available on the company website: www.china-zmc.com .
